Get started
savepiginvest

BLA for Narsoplimab in HSCT-TMA Accepted for Priority Review

Long
Omeros Corporation (NASDAQ:OMER)  
savepiginvest  
NASDAQ:OMER   Omeros Corporation
Beyond Technical Analysis omeros narsoplimab biotech
0
0
beyondta omeros narsoplimab biotech
Biologics License Application for Narsoplimab in HSCT-TMA Accepted for Priority Review by U.S. FDA
-- FDA sets PDUFA date of July 17, 2021 --
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.